A Study To Evaluate PF-05175157 In Healthy Volunteers

Status:
Completed

Trial end date:
2012-05-01

Target enrollment:

Participant gender:

The primary purpose of this study is to evaluate the pharmacodynamics of single oral doses of PF-05175157 in healthy volunteers

Phase 1

Pfizer